
|Articles|September 24, 2015
Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLC
Author(s)Lecia V. Sequist
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.
Advertisement
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene. T790M is the primary cause of treatment resistance in EGFR-positive patients with non-small cell lung cancer (NSCLC).
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Real-Time Text Tool Tracks Quality of Life in Myeloma Care
2
Breaking Down the Prostate Cancer Treatment Renaissance
3
A Closet Full of Boobs and the Thought That Caught Me by Surprise
4
Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma
5





